CJC-1295 No DAC + Ipamorelin

$250per vial

Strength: 5 mg / 5 mg — 10 mg total

SKU: HRP-CJCIPA-10

≥99% purity specification

Supplied for Research Use Only — laboratory research and development

Product Description

This research blend contains 5 mg of CJC-1295 No DAC (Modified GRF 1-29) and 5 mg of Ipamorelin, for 10 mg total. CJC-1295 No DAC is presented as a synthetic GHRH analog, while Ipamorelin is presented in the supplied scientific materials as a selective growth hormone secretagogue receptor (GHSR) agonist. The blend is intended for laboratory research into concurrent GHRH-receptor and GHSR signaling, neuroendocrine feedback mechanisms, receptor cross-talk, and peptide-combination effects in cellular models.

Research Applications

In-vitro studies on dual receptor activation involving GHRH and GHSR pathways
Investigation of neuroendocrine feedback mechanisms
Research on peptide-combination effects and receptor cross-talk in cellular signaling

Compliance

This product is supplied for Research Use Only (RUO). Not for human or animal consumption, diagnostic, therapeutic, preventative, or clinical use. Purchaser is responsible for compliance with all applicable laws and institutional requirements.